Veecube Healthcare Pvt Ltd
Levosulpiride (75mg) + Esomeprazole (40mg)
Esocube LS 75mg/40mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule SR
Esocube LS 75mg/40mg Capsule SR is a prescription medicine used in the treatment of gastroesophageal reflux disease (acid reflux). It works by relieving the symptoms such as heartburn, stomach pain, or irritation. It also neutralizes the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Esocube LS 75mg/40mg Capsule SR is to be taken empty stomach.
Esocube LS 75mg/40mg Capsule SR is a combination of two medicines: Levosulpiride and Esomeprazole.
Do not consume alcohol while taking Esocube LS 75mg/40mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Esocube LS 75mg/40mg Capsule SR for longer than prescribed.
Store Esocube LS 75mg/40mg Capsule SR in its original container, tightly closed, according to the instructions on the packaging or label. Dispose of any unused medication, ensuring it is not accessible to pets, children, or other individuals.
Take Esocube LS 75mg/40mg Capsule SR exactly as directed by your doctor. It is recommended to take one capsule daily on an empty stomach.
Avoid using Esocube LS 75mg/40mg Capsule SR if you have a known allergy to any of its components or excipients.
Yes, Esocube LS 75mg/40mg Capsule SR may cause dizziness (feeling faint, weak, unsteady, or lightheaded) in some patients. If you experience dizziness, it is recommended to rest for a while and resume once you feel better. If your symptoms persist or worsen, consult your doctor.
Several studies suggest that treatment with Esocube LS 75mg/40mg Capsule SR may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine. This risk may be higher in patients who receive high doses or long-term therapy (a year or longer). If you have concerns about your risk of fracture, consult your doctor.